Thomas Mercher

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 22

Top Venues

Leukemia

Blood cancer discovery

HemaSphere

Blood

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Mercher, Juerg Schwaller
From hypoxia single-cell gene signatures to HIF targeting of AML leukemic stem cells. HemaSphere 8 (3) (2024)
Alexandre Fagnan, Zakia Aid, Marie Baille, Aneta Drakul, Elie Robert, Cécile K Lopez, Cécile Thirant, Yann Lecluse, Julie Rivière, Cathy Ignacimouttou, Silvia Salmoiraghi, Eduardo Anguita, Audrey Naimo, Christophe Marzac, Françoise Pflumio, Sébastien Malinge, Christian Wichmann, Yun Huang, Camille Lobry, Julie Chaumeil, Eric Soler, Jean-Pierre Bourquin, Claus Nerlov, Olivier A Bernard, Juerg Schwaller, Thomas Mercher
The ETO2 transcriptional cofactor maintains acute leukemia by driving a MYB/EP300-dependent stemness program. HemaSphere 8 (6) (2024)
Thomas Mercher, Juerg Schwaller
From hypoxia single-cell gene signatures to HIF targeting of AML leukemic stem cells. HemaSphere 8 (3) (2024)
Alexandre Fagnan, Zakia Aid, Marie Baille, Aneta Drakul, Elie Robert, Cécile K Lopez, Cécile Thirant, Yann Lecluse, Julie Rivière, Cathy Ignacimouttou, Silvia Salmoiraghi, Eduardo Anguita, Audrey Naimo, Christophe Marzac, Françoise Pflumio, Sébastien Malinge, Christian Wichmann, Yun Huang, Camille Lobry, Julie Chaumeil, Eric Soler, Jean-Pierre Bourquin, Claus Nerlov, Olivier A Bernard, Juerg Schwaller, Thomas Mercher
The ETO2 transcriptional cofactor maintains acute leukemia by driving a MYB/EP300-dependent stemness program. HemaSphere 8 (6) (2024)
Cécile K Lopez, Thomas Mercher
ERGonomics for EVI1 acute myeloid leukemia. Blood 141 (5) (2023)
Thomas Mercher
ETS Fight Club on Microsatellite Enhancers. Blood cancer discovery 4 (1) (2023)
Thomas Mercher
ETS Fight Club on Microsatellite Enhancers. Blood cancer discovery 4 (1) (2023)
Cécile K Lopez, Thomas Mercher
ERGonomics for EVI1 acute myeloid leukemia. Blood 141 (5) (2023)
Cécile K Lopez, Thomas Mercher
ERGonomics for EVI1 acute myeloid leukemia. Blood 141 (5) (2023)
Thomas Mercher
ETS Fight Club on Microsatellite Enhancers. Blood cancer discovery 4 (1) (2023)
Thomas Mercher
ETS Fight Club on Microsatellite Enhancers. Blood cancer discovery 4 (1) (2023)
Zakia Aid, Elie Robert, Cécile K Lopez, Maxence Bourgoin, Fabien Boudia, Melchior Le Mene, Julie Riviere, Marie Baille, Salima Benbarche, Laurent Renou, Alexandre Fagnan, Cécile Thirant, Laetitia Federici, Laure Touchard, Yann Lecluse, Anton Jetten, Didier Frappaz, Hélène Lapillonne, Eric Solary, Muriel Gaudry, Soheil Meshinchi, Francoise Pflumio, Patrick Auberger, Camille Lobry, Arnaud Petit, Arnaud Jacquel, Thomas Mercher
High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia. Leukemia (2022)
Zakia Aid, Elie Robert, Cécile K Lopez, Maxence Bourgoin, Fabien Boudia, Melchior Le Mene, Julie Riviere, Marie Baille, Salima Benbarche, Laurent Renou, Alexandre Fagnan, Cécile Thirant, Laetitia Federici, Laure Touchard, Yann Lecluse, Anton Jetten, Didier Frappaz, Hélène Lapillonne, Eric Solary, Muriel Gaudry, Soheil Meshinchi, Francoise Pflumio, Patrick Auberger, Camille Lobry, Arnaud Petit, Arnaud Jacquel, Thomas Mercher
High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia. Leukemia 37 (3) (2022)
Zakia Aid, Elie Robert, Cécile K Lopez, Maxence Bourgoin, Fabien Boudia, Melchior Le Mene, Julie Riviere, Marie Baille, Salima Benbarche, Laurent Renou, Alexandre Fagnan, Cécile Thirant, Laetitia Federici, Laure Touchard, Yann Lecluse, Anton Jetten, Didier Frappaz, Hélène Lapillonne, Eric Solary, Muriel Gaudry, Soheil Meshinchi, Francoise Pflumio, Patrick Auberger, Camille Lobry, Arnaud Petit, Arnaud Jacquel, Thomas Mercher
High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia. Leukemia 37 (3) (2022)
Zakia Aid, Elie Robert, Cécile K Lopez, Maxence Bourgoin, Fabien Boudia, Melchior Le Mene, Julie Riviere, Marie Baille, Salima Benbarche, Laurent Renou, Alexandre Fagnan, Cécile Thirant, Laetitia Federici, Laure Touchard, Yann Lecluse, Anton Jetten, Didier Frappaz, Hélène Lapillonne, Eric Solary, Muriel Gaudry, Soheil Meshinchi, Francoise Pflumio, Patrick Auberger, Camille Lobry, Arnaud Petit, Arnaud Jacquel, Thomas Mercher
High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia. Leukemia (2022)
Zakia Aid, Elie Robert, Cécile K Lopez, Maxence Bourgoin, Fabien Boudia, Melchior Le Mene, Julie Riviere, Marie Baille, Salima Benbarche, Laurent Renou, Alexandre Fagnan, Cécile Thirant, Laetitia Federici, Laure Touchard, Yann Lecluse, Anton Jetten, Didier Frappaz, Hélène Lapillonne, Eric Solary, Muriel Gaudry, Soheil Meshinchi, Francoise Pflumio, Patrick Auberger, Camille Lobry, Arnaud Petit, Arnaud Jacquel, Thomas Mercher
High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia. Leukemia 37 (3) (2022)
Thomas Mercher
ETS Fight Club on Microsatellite Enhancers. Blood cancer discovery (2022)
Salima Benbarche, Cécile K Lopez, Eralda Salataj, Zakia Aid, Cécile Thirant, Marie-Charlotte Laiguillon, Séverine Lecourt, Yannis Belloucif, Camille Vaganay, Marion Antonini, Jiang Hu, Alexandra da Silva Babinet, Delphine Ndiaye-Lobry, Bryann Pardieu, Arnaud Petit, Alexandre Puissant, Julie Chaumeil, Thomas Mercher, Camille Lobry
Screening of ETO2-GLIS2-induced Super Enhancers identifies targetable cooperative dependencies in acute megakaryoblastic leukemia. Science advances 8 (6) (2022)
Zakia Aid, Elie Robert, Cécile K Lopez, Maxence Bourgoin, Fabien Boudia, Melchior Le Mene, Julie Riviere, Marie Baille, Salima Benbarche, Laurent Renou, Alexandre Fagnan, Cécile Thirant, Laetitia Federici, Laure Touchard, Yann Lecluse, Anton Jetten, Didier Frappaz, Hélène Lapillonne, Eric Solary, Muriel Gaudry, Soheil Meshinchi, Francoise Pflumio, Patrick Auberger, Camille Lobry, Arnaud Petit, Arnaud Jacquel, Thomas Mercher
High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia. Leukemia 37 (3) (2022)
Anouchka P Laurent, Aurélie Siret, Cathy Ignacimouttou, Kunjal Panchal, M'Boyba Diop, Silvia Jenni, Yi-Chien Tsai, Damien Roosweil, Zakia Aid, Nais Prade, Stephanie Lagarde, Damien Plassard, Gaëlle Pierron, Estelle Daudigeos, Yann Lecluse, Nathalie M Droin, Beat C Bornhauser, Laurence C Cheung, John D Crispino, Muriel Gaudry, Olivier A Bernard, Elizabeth Macintyre, Carole Barin Bonnigal, Rishi Sury Kotecha, Didier Frappaz, Paola Ballerini, Jean-Pierre Bourquin, Eric Delabesse, Thomas Mercher, Sebastien Malinge
Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (13) (2020)
Damien Roosweil, Camille Decaudin, Marine Armand, Véronique Della-Valle, M'boyba K Diop, Hussein Ghamlouch, Virginie Ropars, Cécile Hérate, Diane Lara, Eric Durot, Rima Haddad, Elena Mylonas, Frederik Damm, Francoise Pflumio, Bilyana Stoilova, Marlen Metzner, Olivier Elemento, Philippe Dessen, Valérie Camara-Clayette, François-Loïc Cosset, Els Verhoeyen, Véronique Leblond, Vincent Ribrag, Pascale Cornillet-Lefebvre, Philippe Rameau, Nabih Azar, Frédéric Charlotte, Pierre Morel, Jean-Baptiste Charbonnier, Paresh Vyas, Thomas Mercher, Said Aoufouchi, Nathalie Droin, Christel Guillouf, Florence Nguyen-Khac, Olivier A Bernard
A Recurrent Activating Missense Mutation in Waldenström Macroglobulinemia Affects the DNA Binding of the ETS Transcription Factor SPI1 and Enhances Proliferation. Cancer discovery 9 (6) (2019)
Cécile K Lopez, Esteve Noguera, Vaia Stavropoulou, Elie Robert, Zakia Aid, Paola Ballerini, Chrystèle Bilhou-Nabera, Hélène Lapillonne, Fabien Boudia, Cécile Thirant, Alexandre Fagnan, Marie-Laure Arcangeli, Sarah J Kinston, M'Boyba Diop, Bastien Job, Yann Lecluse, Erika Brunet, Loélia Babin, Jean Luc Villeval, Eric Delabesse, Antoine H F M Peters, William Vainchenker, Muriel Gaudry, Riccardo Masetti, Franco Locatelli, Sebastien Malinge, Claus Nerlov, Nathalie M Droin, Camille Lobry, Isabelle Godin, Olivier A Bernard, Berthold Göttgens, Arnaud Petit, Françoise Pflumio, Juerg Schwaller, Thomas Mercher
Ontogenic Changes in Hematopoietic Hierarchy Determine Pediatric Specificity and Disease Phenotype in Fusion Oncogene-Driven Myeloid Leukemia. Cancer discovery 9 (12) (2019)

Thomas Mercher.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Mercher